CAP256V2LS
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CAP256V2LS, covering 2023-12-18 to 2026-01-16. Get the full timeline:
Most recent: Clinical Trial Update: Study of VRC07-523LS, CAP256V2LS, and Vesatolimod, in Early Antiretroviral-treated HIV-1 Clade C-infected Women [Phase 2]